IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10%

Approval Id: f935675fe154c87a
Drug Approval Canada Name: IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10%
Product Name: IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10%
Status: Cancelled Post Market
Status Date: 2006-08-03
Original Market Date: 2000-07-31
Din: 02230920
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 80:04.00
Atc Original: J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Atc Name: j 06 ba 02
Aig Number: 0106267015
Company Name: TALECRIS BIOTHERAPEUTICS INC
Company Address: 8368 Us 70 Business Hwy. West, Clayton, North Carolina, United States, 27520-9464
Company Detail Path: /organization/talecris-biotherapeutics-inc-raleigh-north-carolina-united-states

IMMUNOGLOBULIN (HUMAN)

10 G / 100 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f935675fe154c87a

Type

Standard